Inovio Pharmaceuticals
INO
#9645
Rank
C$0.16 B
Marketcap
C$1.64
Share price
-5.60%
Change (1 day)
-47.75%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2026 (TTM): C-$3.16

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is C-$3.16. In 2025 the company made an earnings per share (EPS) of C-$2.52 an increase over its 2024 EPS that were of C-$5.49.

EPS history for Inovio Pharmaceuticals from 1999 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$3.1625.73%
2025C-$2.52-54.18%
2024C-$5.49-35.14%
2023C-$8.47-56.62%
2022C-$19.52-19.54%
2021C-$24.2735.9%
2020C-$17.85-11.57%
2019C-$20.1915.24%
2018C-$17.52-2.78%
2017C-$18.026.93%
2016C-$16.85134.88%
2015C-$7.18-29.51%
2014C-$10.18-57.34%
2013C-$23.86146.55%
2012C-$9.6820.83%
2011C-$8.01-29.41%
2010C-$11.35-48.48%
2009C-$22.0310%
2008C-$20.0211.11%
2007C-$18.02-41.3%
2006C-$30.70-66.91%
2005C-$92.78110.61%
2004C-$44.05-61.63%
2003C-$114.80186.67%
2002C-$40.05
2001N/A-100%
2000C-$32.04-63.64%
1999C-$88.11

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$12.15-484.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$9.76-409.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$1.82-157.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$10.32-426.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$4.97-257.48%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$5.40-271.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
C$1.13-135.68%๐Ÿ‡บ๐Ÿ‡ธ USA